Skip to main content
Retour
Watch Compare

Translational Development Acquisition Corp.

Qualité des données : 67%
Également cotée sous TDACW Nasdaq
TDACU
Nasdaq Financial Services Holding & Investment Offices
10,40 €
0,00 € (0,00%)
Prix
10,40 €
Cap. Boursière
N/A
Fourchette du Jour
10,40 € — 10,40 €
Fourchette 52 Semaines
10,13 € — 10,90 €
Volume
0
Ouverture 0,00 €
Moyenne 50J / 200J
10,44 €
0,38% below
Moyenne 50J / 200J
10,42 €
0,23% below

Quick Summary

Points Clés

Negative free cash flow of -608 387,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-0,42%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,19
Interest CoverageN/A

Valorisation

P/E Ratio
N/A
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Financial Services (2150 pairs)
Métrique Action Médiane du Secteur
P/E — 11,2
P/B — 1,2
ROE % — 9,2
Net Margin % — 9,4
Rev Growth 5Y % — 5,8
D/E — 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) 6,36 M
ROE N/A ROA 3,55%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -608 387,0
ROIC -0,42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,19
Interest Coverage N/A Asset Turnover N/A
Working Capital -342 263 Tangible Book Value -6,38 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio N/A Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap N/A Enterprise Value N/A
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -9,56%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income 6,36 M -71 012,0
EPS (Diluted) — —
Gross Profit — —
Operating Income -944 538,0 -196 358,0
EBITDA — —
R&D Expenses — —
SG&A Expenses — —
D&A — —
Interest Expense — —
Income Tax — 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 181,70 M 175,00 M
Total Liabilities 6,58 M 6,25 M
Shareholders' Equity -6,54 M -5,60 M
Total Debt — —
Cash & Equivalents 29 787,0 438 174,0
Current Assets 39 465,0 650 233,0
Current Liabilities 544 073,0 210 303,0